Cargando…
Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance
Glaucoma is a neurodegenerative disease that affects primarily the retinal ganglion cells (RGCs). Increased intraocular pressure (IOP) is one of the major risk factors for glaucoma. The mainstay of current glaucoma therapy is limited to lowering IOP; however, controlling IOP in certain patients can...
Autores principales: | Kuo, Che-Yuan, Liu, Catherine Jui-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697907/ https://www.ncbi.nlm.nih.gov/pubmed/36579616 http://dx.doi.org/10.3390/jpm12111884 |
Ejemplares similares
-
Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016) -
Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022) -
Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016) -
Neuroprotective therapies for glaucoma
por: Song, Wei, et al.
Publicado: (2015) -
Neuroprotection in glaucoma-electrophysiology
por: Lešták, Ján, et al.
Publicado: (2020)